Quality System and Audit

BlueReg experienced consultants can provide full support in designing and implementing a quality system that meets regulatory expectations in France.

Our services


  • Advice and operational support for pharmaceutical companies located in France for a quality system that meets regulatory expectations for an “Exploitant” status
  • Provision of deputy “Exploitant” Qualified Person (QP)
  • Risk analysis / process mapping
  • Advice, review or preparation of:
    • Product Quality Reviews (PQR)
    • Client-customised standard operating procedures (SOPs) or quality manuals,
    • Quality technical agreements
    • Application for obtaining the “Exploitant” status from the French National Agency for the Safety of Medicines and Health Products (ANSM) and annual reports
    • Contingency plans for drug shortage (shortage management plans (PGP)) for medicinal products of major therapeutic interest (MITM)
    • Serialisation

  • Audits of pharmaceutical processes according to good manufacturing practice (GMP), good distribution practice (GDP) or “Exploitant” activities
  • Preparation and support prior to ANSM inspection


BlueReg understands the requirements of the health authorities concerning audits and what to expect. Thus, we can provide a complete audit preparation package which we can tailor to your needs, including:


  • Standard Operating Procedure (SOP) reviewing/writing
  • Pharmacovigilance System Master File (PSMF) reviewing/writing
  • Corrective Action Preventive Action (CAPA) review
  • Setting up/reviewing a Quality Management System (QMS)
  • Data review of relevant documentation/certification/procedures
  • Conducting audits of sites (internal/third party)
  • Conducting mock audits
  • Providing support on-site during the audit
  • Pre-audit training to staff


All these activities are carried out in full compliance with Good Clinical Practices, Good Manufacturing Practices, Good Vigilance Practices and local standards as applicable.

Product Down jacket

Associated services

BlueReg experienced consultants can provide full support in designing and implementing a quality system that meets regulatory expectations in France.


Associated services

Pricing and reimbursement (Drugs and Medical devices)

BlueReg consultants can provide pricing and reimbursement insight and support you prior to the launch of your products in France. BlueReg has a team of Market Access experts dedicated to supporting your company through the full pricing and reimbursement process (medicinal products and medical devices).

Associated services

Exploitant Services

Looking for support in marketing your product in France? PharmaBlue, a BlueReg company, is a partner “Exploitant” of pharmaceutical companies for the marketing in France of their medicinal products which have been granted a temporary use authorization (ATU) or a marketing authorisation (MA).

Associated News

The French system for preventing and managing shortages

The French regulation on the prevention and management of stock shortages of medicinal products is...

Learn more

Consulting Regulatory Affairs Services for Pharmaceutical companies

  The regulatory affairs process is a critical component of the safe development, registration and...

Learn more

Corinne Schmitz, CEO of BlueReg, winner of the Women Equity 2020 Award

Doctor of Pharmacy, Corinne Schmitz has worked for more than twenty years in the pharmaceutical...

Learn more

Line - Organism